Literature DB >> 22876530

Growth failure in children with cystic fibrosis.

Alessandra Scaparrotta1, Sabrina Di Pillo, Marina Attanasi, Nicola Pietro Consilvio, Anna Cingolani, Daniele Rapino, Angelika Mohn, Francesco Chiarelli.   

Abstract

Poor linear growth and inadequate weight gain are very common problems in cystic fibrosis (CF) children. The most important factors involved in growth failure are undernutrition or malnutrition, chronic inflammation, lung disease, and corticosteroid treatment. Nutritional support and pharmacological therapy with recombinant human growth hormone are essential for a good management of children with CF, although these children are shorter and lighter than healthy children, and despite the catch-up growth observed after diagnosis, deficit in length/height and weight continues to be seen until adulthood. Early diagnosis is essential to ensure better nutritional status and growth, potentially associated with better respiratory function and prognosis. The aims of this review are try to explain etiology and pathogenetic mechanisms of growth failure in CF children and clarify their role in the disease morbidity and in clinical outcome, especially in relation to progressive decline of pulmonary function.

Entities:  

Mesh:

Year:  2012        PMID: 22876530     DOI: 10.1515/jpem-2012-0012

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  14 in total

1.  Deregulation of the growth hormone/insulin-like growth factor-1 axis in adults with cystic fibrosis.

Authors:  C Pascucci; R V De Biase; D Savi; S Quattrucci; A M Isidori; C Lubrano; L Gnessi; A Lenzi
Journal:  J Endocrinol Invest       Date:  2017-11-02       Impact factor: 4.256

Review 2.  Diagnosis and treatment of endocrine comorbidities in patients with cystic fibrosis.

Authors:  Oranan Siwamogsatham; Jessica A Alvarez; Vin Tangpricha
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-10       Impact factor: 3.243

3.  Body mass index and waist circumference of HIV-infected youth in a Miami cohort: comparison to local and national cohorts.

Authors:  Lori E Arbeitman; Robert C O'Brien; Gabriel Somarriba; Sarah E Messiah; Daniela Neri; Gwendolyn B Scott; Tracie L Miller
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-10       Impact factor: 2.839

4.  Optimizing Estimated Glomerular Filtration Rate to Support Adult to Pediatric Pharmacokinetic Bridging Studies in Patients with Cystic Fibrosis.

Authors:  Ryan L Crass; Manjunath P Pai
Journal:  Clin Pharmacokinet       Date:  2019-10       Impact factor: 6.447

5.  Demographic, clinical, and laboratory parameters of cystic fibrosis during the last two decades: a comparative analysis.

Authors:  Fernando Augusto de Lima Marson; Tais Daiene Russo Hortencio; Katia Cristina Alberto Aguiar; Jose Dirceu Ribeiro
Journal:  BMC Pulm Med       Date:  2015-01-15       Impact factor: 3.317

6.  Evidence for a Cystic Fibrosis Enteropathy.

Authors:  Marlou P M Adriaanse; Linda J T M van der Sande; Anita M van den Neucker; Paul P C A Menheere; Edward Dompeling; Wim A Buurman; Anita C E Vreugdenhil
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

7.  A G542X cystic fibrosis mouse model for examining nonsense mutation directed therapies.

Authors:  Daniel R McHugh; Miarasa S Steele; Dana M Valerio; Alexander Miron; Rachel J Mann; David F LePage; Ronald A Conlon; Calvin U Cotton; Mitchell L Drumm; Craig A Hodges
Journal:  PLoS One       Date:  2018-06-20       Impact factor: 3.240

8.  Automatic referrals within a cystic fibrosis multidisciplinary clinic improve patient evaluation and management.

Authors:  Amy Darukhanavala; Ted Kremer
Journal:  J Clin Transl Endocrinol       Date:  2021-06-12

9.  ASSOCIATION OF NUTRITIONAL STATUS WITH LUNG FUNCTION AND MORBIDITY IN CHILDREN AND ADOLESCENTS WITH CYSTIC FIBROSIS: A 36-MONTH COHORT STUDY.

Authors:  Daniela Barbieri Hauschild; Anauã Franco Rosa; Julia Carvalho Ventura; Eliana Barbosa; Emília Addison Machado Moreira; Norberto Ludwig Neto; Yara Maria Franco Moreno
Journal:  Rev Paul Pediatr       Date:  2018-01-15

Review 10.  Transcriptomic and Proteostasis Networks of CFTR and the Development of Small Molecule Modulators for the Treatment of Cystic Fibrosis Lung Disease.

Authors:  Matthew D Strub; Paul B McCray
Journal:  Genes (Basel)       Date:  2020-05-13       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.